scholarly journals Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?

Cancer ◽  
2002 ◽  
Vol 95 (6) ◽  
pp. 1334-1345 ◽  
Author(s):  
Andrea Baur ◽  
Axel Stäbler ◽  
Dorothea Nagel ◽  
Rolf Lamerz ◽  
Reiner Bartl ◽  
...  
Keyword(s):  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Staging System ◽  
Clinical Staging ◽  
Resonance Imaging ◽  
Clinical Staging System

A comparative study of computerized tomography, magnetic resonance imaging, and clinical staging for the detection of early cervix cancer

1990 ◽  
Vol 36 (3) ◽  
pp. 409-412 ◽  
Author(s):  
Michael Brodman ◽  
Frederick Friedman ◽  
Peter Dottino ◽  
Cynthia Janus ◽  
Steven Plaxe ◽  
...  
Keyword(s):  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Comparative Study ◽  
Computerized Tomography ◽  
Cervix Cancer ◽  
Clinical Staging ◽  
Resonance Imaging

Arguments for a magnetic resonance imaging–assisted FIGO staging system for cervical cancer

2005 ◽  
Vol 15 (4) ◽  
pp. 573-582 ◽  
Author(s):  
K. Narayan
Keyword(s):  
Magnetic Resonance Imaging ◽  
Cervical Cancer ◽  
Magnetic Resonance ◽  
Cancer Biology ◽  
Surgical Techniques ◽  
Staging System ◽  
Combined Modality Treatment ◽  
Resonance Imaging ◽  
Figo Staging ◽  
Patient Selection Criteria

FIGO staging of cervical cancer is based on anatomic compartmental spread of cervical cancer. This was necessary in the evaluation of surgical resectability in each patient. Even if the surgical resection was not deemed satisfactory, surgical findings and subsequent accurate anatomic pathology findings could be used to prescribe tailored adjuvant therapies. Recently, the management of cervical cancer has been influenced by the evidence from several surgical-pathologic studies and phase II and III combined modality treatment trials. However, the patient selection criteria used in these clinical studies were almost always refined by modern medical imaging and surgical techniques not prescribed in the FIGO staging system. The results obtained from these studies would not correlate with those from the patient population similarly treated but selected strictly along the FIGO staging criteria. This selective, heterogenous, and arbitrary refinement of FIGO staging has certainly given insight into cervical cancer biology but in the process has rendered the current FIGO staging of this disease quite inadequate. Prior knowledge of these factors through modern imaging in these patients could be used in staging and selecting the optimum treatment modality while minimizing the treatment-related morbidity. A magnetic resonance imaging-assisted FIGO staging system for cervical cancer as proposed here could be used for selecting patients appropriately for a given treatment package

Role of Magnetic Resonance Imaging as an Adjunct to Clinical Staging in Cervical Carcinoma

2010 ◽  
Vol 34 (6) ◽  
pp. 855-864 ◽  
Author(s):  
Priya Bhosale ◽  
Silanath Peungjesada ◽  
Catherine Devine ◽  
Aparna Balachandran ◽  
Revathy Iyer
Keyword(s):  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Cervical Carcinoma ◽  
Clinical Staging ◽  
Resonance Imaging

scholarly journals Diagnostic Accuracy of Magnetic Resonance Imaging versus Clinical Staging in Cervical Cancer

2014 ◽  
Vol 15 (14) ◽  
pp. 5729-5732 ◽  
Author(s):  
Ahmad Soltani Shirazi ◽  
Taghi Razi ◽  
Fatemeh Cheraghi ◽  
Fakher Rahim ◽  
Sara Ehsani ◽  
...  
Keyword(s):  
Magnetic Resonance Imaging ◽  
Cervical Cancer ◽  
Magnetic Resonance ◽  
Diagnostic Accuracy ◽  
Clinical Staging ◽  
Resonance Imaging

Clinical significance of diffusion-weighted whole body magnetic resonance imaging with background body signal suppression (DWIBS) as a staging procedure for lymphoma patients in comparison with FDG-PET

2007 ◽  
Vol 25 (18_suppl) ◽  
pp. 8084-8084
Author(s):  
T. Itoyama ◽  
T. Shibuya ◽  
T. Koga ◽  
M. Kitagawa ◽  
T. Yoshida ◽  
...  
Keyword(s):  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Clinical Significance ◽  
Fdg Pet ◽  
Clinical Staging ◽  
Whole Body ◽  
Resonance Imaging ◽  
Diffusion Weighted ◽  
Signal Suppression ◽  
Body Magnetic Resonance Imaging

8084 Background: FDG-PET is thought to be an important staging tool in lymphomas. However, high cost and exposure to radioactive agents are of disadvantage. Diffusion weighted whole body magnetic resonance imaging with background body signal suppression (DWIBS) is recently reported to be a new way of magnetic resonance imaging which can make FDG-PET-like imaging possible to detect tumors (Takahara et al; Radiation Medicine 22: 275–282, 2004). This study is aimed to compare accuracy and clinical significance of DWIBS to FDG - PET. Methods: We examined 19 lymphoma (Ly) patients (pts) by using both DWIBS and FDG -PET at the time of diagnosis before therapy. There were follicular Ly in 3 pts, nodal marginal zone Ly in 1, diffuse large B-cell Ly in 9 including primary stomach Ly in 2, peripheral T -cell Ly in 4, and MALT Ly of stomach (GI-MALT) in 2. DWIBS was performed with a 1.5 -Tesla system as previously reported (Ochiai et al; Nichidoku -Iho 50: 86–98, 2005). Clinical staging was made according to the Ann Arbor classification. Results: Both DWIBS and FDG -PET had positive findings in 18 of 19 pts except for a case of GI -MALT. In nodal lesions, DWIBS was positive in 16 pts at 66 sites compared to 16 pts at 68 sites with FDG -PET. DWIBS was negative in 3 pts at 5 sites in spleen, hilar and mediastinal lymphnodes where positive in FDG -PET. DWIBS was positive in 2 pts at 4 sites in iliac and inguinal lymphnodes that are negative in FDG -PET. In extranodal lesions, DWIBS was positive in 12 pts at 17 sites as compared to 12 pts at 18 sites with FDG -PET. Involvement of bone and stomach were equally identified at 8 sites. DWIBS was negative in 2 pts at 2 sites in liver and pleura with FDG -PET positive. Small skin lesions were clearly identified on DWIBS. Discordance of clinical staging was not observed between DWIBS and FDG -PET. Conclusions: Although some discrepancy was seen between DWIBS and FDG -PET, there was no disadvantage of DWIBS compared to FDG -PET. Furthermore, DWIBS has no risk of radiation exposure and is even advantageous to detect lesions with FDG -PET negative. We conclude DWIBS is a new useful tool to assess tumor spread in lymphomas. No significant financial relationships to disclose.

Sign in / Sign up

Export Citation Format

Share Document